Immunotherapy combined with rh-endostatin improved clinical outcomes over immunotherapy plus chemotherapy for second-line treatment of advanced NSCLC
Article in Frontiers in Oncology (March 2023)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (March 2023)
Article in Oncolog-Hematolog ro (January 2023)
Article in Frontiers in Oncology (August 2021)